- Home
- AQST vs MFIN Comparison
AQST vs MFIN Comparison
Compare AQST & MFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- MFIN
- Stock Information
- Founded
- AQST 2004
- MFIN 1995
- Country
- AQST United States
- MFIN United States
- Employees
- AQST N/A
- MFIN N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- MFIN Finance: Consumer Services
- Sector
- AQST Health Care
- MFIN Finance
- Exchange
- AQST Nasdaq
- MFIN Nasdaq
- Market Cap
- AQST 272.9M
- MFIN 224.2M
- IPO Year
- AQST 2018
- MFIN 1996
- Fundamental
- Price
- AQST $4.06
- MFIN $9.55
- Analyst Decision
- AQST Strong Buy
- MFIN
- Analyst Count
- AQST 7
- MFIN 0
- Target Price
- AQST $11.29
- MFIN N/A
- AVG Volume (30 Days)
- AQST 1.3M
- MFIN 69.5K
- Earning Date
- AQST 08-05-2025
- MFIN 07-29-2025
- Dividend Yield
- AQST N/A
- MFIN 5.08%
- EPS Growth
- AQST N/A
- MFIN N/A
- EPS
- AQST N/A
- MFIN 1.60
- Revenue
- AQST $54,228,000.00
- MFIN $316,751,000.00
- Revenue This Year
- AQST N/A
- MFIN N/A
- Revenue Next Year
- AQST $45.71
- MFIN $5.24
- P/E Ratio
- AQST N/A
- MFIN $5.90
- Revenue Growth
- AQST 5.29
- MFIN 13.91
- 52 Week Low
- AQST $2.12
- MFIN $7.21
- 52 Week High
- AQST $5.80
- MFIN $10.50
- Technical
- Relative Strength Index (RSI)
- AQST 72.86
- MFIN 51.74
- Support Level
- AQST $3.62
- MFIN $9.31
- Resistance Level
- AQST $3.80
- MFIN $9.98
- Average True Range (ATR)
- AQST 0.19
- MFIN 0.34
- MACD
- AQST 0.05
- MFIN -0.01
- Stochastic Oscillator
- AQST 95.43
- MFIN 43.86
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About MFIN Medallion Financial Corp.
Medallion Financial Corp is a finance company that originates and services loans in various industries. The five operating segments are, (1) recreation, (2) home improvement, (3) commercial, (4) taxi medallion, and (5) strategic partnership loans. The company generates maximum revenue from the Recreation segment.